Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT04987931 · COMPLETED
Trial details
- NCT number
- NCT04987931
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-20
- Primary completion
- 2021-10-11
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.